About Sumatriptan Succinate API

CH₃ H₃C-O N
Therapeutic Category Anti Migraine
CAS Number 103628-48-4
API Technology Synthesis / Small Molecule
Dose Form Tablets
Synergene's Development Status Available
Available Regulatory Filing ODMF, USDMF

Mechanism of Action

Sumatriptan Succinate operates through targeted therapeutic pathways for anti migraine applications. Detailed pharmacological specifications are available upon technical request.

Indication

Indicated for pharmaceutical therapeutic applications in Anti Migraine disorders.